Physiological role of AMP-activated protein kinase in the heart: Graded activation during exercise

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 3 48-3, 2003, Pages

  Coven, David L ^a   Hu, Xiaoyue ^a   Cong, Lin ^a   Bergeron, Raynald ^a   Shulman, Gerald I ^a   Hardie, D Grahame ^b   Young, Lawrence H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Univ School of Medicine ^*

Author keywords

Energy metabolism; Glucose; Signal transduction

Indexed keywords

ADENYLATE KINASE; GLUCOSE TRANSPORTER 4; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXERCISE; HEART MUSCLE ISCHEMIA; HEART WORK; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; REST; SARCOLEMMA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TREADMILL EXERCISE;

EID: 0042466249     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00171.2003     Document Type: Article

References (61)

1. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, and Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci USA 97: 1444-1449, 2000.
2. Abu-Elheiga L, Jayakumar A, Baldini A, Chirala SS, and Wakil SJ. Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms. Proc Natl Acad Sci USA 92: 4011-4015, 1995.
3. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, and Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291: 2613-2616, 2001.
4. Asefaw S, Russell RR, Bergeron R, Hu J, Dione D, Sinusas AJ, and Young LH. Stimulation of AMP-activated protein kinase by AICAR increases heart glucose uptake and GLUT4 and GLUT1 translocation to the sarcolemma in vivo (Abstract). Diabetes 48, Suppl 1: A273, 1999.
5. Beauloye C, Marsin AS, Bertrand L, Vanoverschelde JL, Rider MH, and Hue L. The stimulation of heart glycolysis by increased workload does not require AMP-activated protein kinase but a wortmannin-sensitive mechanism. FEBS Lett 531: 324-328, 2002.
6. Bergeron R, Ren JM, Cadman KS, Moore IK, Perret P, Pypaert M, Young LH, Semenkovich CF, and Shulman GI. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab 281: E1340-E1346, 2001.
7. Bergeron R, Russell RR, Young LH, Ren JM, Marcucci M, Lee A, and Shulman GI. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol Endocrinol Metab 276: E938-E944, 1999.
8. Carling D, Clarke P, Zammit V, and Hardie D. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem 186: 129-136, 1989.
9. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, and Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000.
10. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
11. Davies S, Sim A, and Hardie D. Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur J Biochem 187: 183-190, 1990.
12. Dean D, Daugaard JR, Young ME, Saha A, Vavvas D, Asp S, Kiens B, Kim KH, Witters L, Richter EA, and Ruderman N. Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 49: 1295-1300, 2000.
13. Doenst T and Taegtmeyer H. Alpha-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart. Circ Res 84: 467-474, 1999.
14. Dyck JR, Kudo N, Barr AJ, Davies SP, Hardie DG, and Lopaschuk GD. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5′-AMP activated protein kinase. Eur J Biochem 262: 184-190, 1999.
15. Frederich M and Balschi JA. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J Biol Chem 277: 1928-1932, 2002.
16. Fryer LG, Foufelle F, Barnes K, Baldwin SA, Woods A, and Carling D. Characterization of the role of the AMP-activated protein kinase in the stimulation of glucose transport in skeletal muscle cells. Biochem J 363: 167-174, 2002.
17. Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, and Goodyear LJ. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273: 1150-1155, 2000.
18. Gertz EW, Wisneski JA, Stanley WC, and Neese RA. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 82: 2017-2025, 1988.
19. Goldfarb AH, Bruno JF, and Buckenmeyer PJ. Intensity and duration effects of exercise on heart cAMP, phosphorylase, and glycogen. J Appl Physiol 60: 1268-1273, 1986.
20. Ha J, Daniel S, Broyles SS, and Kim KH. Critical phosphorylation sites for acetyl-CoA carboxylase activity. J Biol Chem 269: 22162-22168, 1994.
21. Hall J, Lopaschuk G, Barr A, Bringas J, Pizzurro R, and Stanley W. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. Cardiovasc Res 32: 879-885, 1996.
22. Hardie DG and Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997.
23. Hardie DG, Carling D, and Carlson M. The AMP-activated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
24. Hardie DG, Salt IP, Hawley SA, and Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338: 717-722, 1999.
25. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, and Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271: 27879-27887, 1996.
26. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, and Goodyear LJ. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49: 527-531, 2000.
27. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
28. Hudson ER, Pan DA, Lucocq JM, Hawley SA, Green KA, Baba O, Terashima T, and Hardie DG. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13: 861-866, 2003.
29. Jacob RJ, Hu X, Niederstock D, Hasan S, McNulty PH, Sherwin RS, and Young LH. IGF-1 stimulation of muscle protein synthesis in the awake rat: permissive role of insulin and amino acids. Am J Physiol Endocrinol Metab 270: E60-E66, 1996.
30. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, and Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24: 22-25, 1999.
31. Kudo N, Barr AJ, Barr RL, Desai S, and Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
32. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, and Lopaschuk GD. Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996.
33. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, and Winder WW. 5′AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1999.
34. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, and Hue L. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10: 1247-1255, 2000.
35. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
36. Mu J, Brozinick JT Jr, Valladares O, Bucan M, and Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094, 2001.
37. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, and Stapleton D. AMPK beta-subunit targets metabolic stress-sensing to glycogen. Curr Biol 13: 867-871, 2003.
38. Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, and Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 17: 1688-1699, 1998.
39. 2+ to stimulate glucose transport and GLUT4 translocation in perfused rat heart. Biochim Biophys Acta 1094: 217-223, 1991.
40. Ruderman NB, Saha AK, Vavvas D, and Witters LE. Malonyl-CoA, fuel sensing and insulin resistance. Am J Physiol Endocrinol Metab 276: E1-E18, 1999.
41. Russell R, Coven D, Zechner C, Palmieri M, Birnbaum M, Mu J, and Young L. Inhibition of increased glycolysis during low flow ischemia in mice with loss of AMPK-activated protein kinase function (Abstract). Circulation 106, Suppl 2: II-162, 2002.
42. Russell RR, Bergeron R, Shulman GI, and Young LH. Translocation of myocardial GLUT4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643-H649, 1999.
43. Saha AK, Schwarsin AJ, Roduit R, Masse F, Kaushik V, Tornheim K, Prentki M, and Ruderman NB. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem 275: 24279-24283, 2000.
44. Sakamoto K, Hirshman MF, Aschenbach WG, and Goodyear LJ. Contraction regulation of Akt in rat skeletal muscle. J Biol Chem 277: 11910-11917, 2002.
45. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, and Hardie DG. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334: 177-187, 1998.
46. Stapleton D, Mitchelhill K, Gao G, Widmer J, Michell B, Teh, House C, Fernandez C, Cox T, Witters L, and Kemp B. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996.
47. Stein SC, Woods A, Jones NA, Davison MD, and Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345: 437-443, 2000.
48. Stephens TJ, Chen Z-P, Canny BJ, Michell BJ, Kemp BE, and McConell GK. Progressive increase in human skeletal muscle AMPKα2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688-E694, 2002.
49. Tian R, Musi N, D'Agostino J, Hirshman MF, and Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104: 1664-1669, 2001.
50. Till M, Ouwens DM, Kessler A, and Eckel J. Molecular mechanisms of contraction-regulated cardiac glucose transport. Biochem J 346: 841-847, 2000.
51. Vavvas D, Apazidis A, Saha A, Gamble J, Patel A, Kemp B, Witters L, and Ruderman N. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272: 13255-13261, 1997.
52. Wahlquist M, Kayser L, Lassers B, and Carlson L. Fatty acid as a determinant of myocardial substrate and oxygen metabolism in man at rest and during prolonged exercise. Acta Med Scand 193: 89-96, 1973.
53. Winder WW and Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270: E299-E304, 1996.
54. Winder WW and Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol Endocrinol Metab 277: E1-E10, 1999.
55. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, and Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82: 219-225, 1997.
56. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, and Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51: 284-292, 2002.
57. Wojtaszewski JF, Mourtzakis M, Hillig T, Saltin B, and Pilegaard H. Dissociation of AMPK activity and ACCbeta phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun 298: 309-316, 2002.
58. Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, and Kiens B. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol 528: 221-226, 2000.
59. Woods A, Salt I, Scott J, Hardie DG, and Carling D. The alphal and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397: 347-351, 1996.
60. Yeh JI, Gulve EA, Rameh L, and Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270: 2107-2111, 1995.
61. Young LH, Renfu Y, Russell RR, Hu X, Caplan MJ, Ren J, Shulman GI, and Sinusas AJ. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95: 415-422, 1997.